This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Akzo N.v.. Active years: 1984-1989.
Company Filing History:
Years Active: 1984-1989
Title: The Innovations of Francois E Van Houdenhoven
Introduction
Francois E Van Houdenhoven is a notable inventor based in Heesch, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified human insulin and anti-thrombotic agents. With a total of 2 patents, his work has had a considerable impact on medical science.
Latest Patents
Van Houdenhoven's latest patents include a novel modified human insulin and its use as a starting material for the preparation of human insulin. This invention features a modified human insulin of the general formula wherein R is a hydrophobic or charged amino acid or a di- or tripeptide group. The second patent focuses on an anti-thromboticum based on polysaccharides, which provides a new product of natural origin that can be obtained from mammal tissue, particularly intestinal mucous. This product is notable for its high 'benefit/risk' ratio, balancing anti-thrombotic activity with minimal hemorrhagic activity.
Career Highlights
Throughout his career, Van Houdenhoven has worked with prominent companies such as Akzo N.V. and Akzo Nobel N.V. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Van Houdenhoven has collaborated with notable individuals in his field, including Gijsbert W Van Dedem and Adrianus L Sanders. These partnerships have likely enhanced his research and development efforts.
Conclusion
Francois E Van Houdenhoven's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective treatments.